The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cytochrome P450 2D6 polymorphisms of Thai patients with breast cancer and their outcomes of adjuvant tamoxifen.
K. Pechatanan
No relevant relationships to disclose
S. Jaruhathai
No relevant relationships to disclose
T. Ativitavas
No relevant relationships to disclose
T. Sirisinha
No relevant relationships to disclose
R. Panvichian
No relevant relationships to disclose
V. Ratanatharathorn
No relevant relationships to disclose
E. Sirachainan
No relevant relationships to disclose